VisageX Medical

Company Overview

Snapshot

Founded in March 2022 by Gideon Meyer Brodnitz, VisageX Medical operates with 1–10 employees. The company has secured funding across four rounds and is currently conducting its First-in-Human (FIH) study for its adjustable implants.

Business overview

VisageX Medical is pioneering a new category in medical implants with its Adjustable Permanent Implants (API) technology. These smart, programmable implants can be reshaped post-implantation using non-invasive induction heating of shape memory materials. The company's vision is to develop a platform of adjustable implants for various clinical applications, including reconstructive, aesthetic, cranial, orthopedic, urological, and ENT indications. VisageX Medical's initial focus is on facial reconstructive implants, addressing critical unmet needs in craniomaxillofacial (CMF) surgery where static implants often necessitate revisions. The company serves the healthcare and life sciences sectors, targeting providers within the medical device and biomaterials markets.

Company Intelligence Q&A

What is VisageX Medical's core innovation in medical implants?

VisageX Medical is developing Adjustable Permanent Implants (API), which are smart, programmable implants designed to be reshaped non-invasively after implantation using induction heating of shape memory materials. This technology aims to address limitations of static implants in various surgical fields.

When was VisageX Medical founded and by whom?

VisageX Medical was founded in March 2022 by Gideon Meyer Brodnitz, who serves as Co-founder & CEO.

What is the primary application of VisageX Medical's initial product?

VisageX Medical's first generation of adjustable implants is focused on facial reconstructive surgery, specifically addressing craniomaxillofacial (CMF) surgery where the ability to reshape implants post-surgery can reduce the need for revisions.

What is the current development stage of VisageX Medical's products?

VisageX Medical is currently in the clinical trial phase, having started its First-in-Human (FIH) study for its adjustable implants.

What is VisageX Medical's long-term vision for its adjustable implant platform?

VisageX Medical's long-term vision is to establish a platform of adjustable implants applicable across a wide range of clinical areas, including reconstructive, aesthetic, cranial, orthopedic, urological, and ENT indications, aiming to become a leader in patient-tailored implants.